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Phosphatidylinositol 5-phosphate (PtdIns5P) is emerging as a potential lipid messenger involved in
several cell types, from plants to mammals. Expression of IpgD, a PtdIns(4, 5)P2 4-phosphatase
induces Src kinase and Akt, but not ERK activation and enhances interleukin II promoter activity
in T-cells. Expression of a new PtdIns5P interacting domain blocks IpgD-induced T-cell activation
and selective signaling molecules downstream of TCR triggering. Altogether, these data suggest that
PtdIns5P may play a sensor function in setting the threshold of T-cell activation and contributing to
maintain T-cell homeostasis.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction plastic large cell lymphomas (ALCLs) [6]. In blood platelets, throm-Phosphoinositides (PIs) are constituents of cell membranes
playing a critical role in cell signaling pathways. Their biosynthesis
is tightly regulated by several lipid kinases and phosphatases,
which disruption can give rise to several pathologies [1]. Among
PIs, phosphatidylinositol 5-phosphate (PtdIns5P) is emerging as a
potential lipid messenger [2,3]. Indeed, enhanced tyrosine phos-
phorylation induced by pervanadate treatment reveals detectable
cellular PtdIns5P levels in epithelial cells [4]. Moreover, stimula-
tion of some receptor tyrosine kinases such as the insulin receptor
induces a PtdIns5P increase [5]. An increase in PtdIns5P levels has
been also reported in hematopoietic cells expressing the oncogenic
tyrosine kinase nucleophosmin anaplastic lymphoma kinase
(NPM-ALK), a chimeric protein found in the large majority of ana-chemical Societies. Published by E
phosphatidylinositol 5-phos-
a Santé et de la Recherche
ologie de Marseille, F-13009
ès).
cisco, 513 Parnassus Avenue,bin stimulation can also increase PtdIns5P production [7]. Bacterial
infection by Shigella ﬂexnerii generates, via the virulence factor
IpgD, PtdIns5P at the plasma membrane of the host cells leading
to Akt activation [8,9].
PtdIns5P has been identiﬁed in different subcellular compart-
ments such as the plasma membrane and the nucleus [3]. These
data suggest that PtdIns5P is entering the large investigation ﬁeld
of signaling pathways.
PIs mediate signals through their binding to proteins containing
speciﬁc interaction domains [10]. Interestingly, we found that Dok-
1/Dok-2 pleckstrin homology (PH) domains bind in vitro to
PtdIns5P [11]. Previous studies have identiﬁed ATX1 and ING2 plant
homeo domain (PHD) as PtdIns5P binding module [12,13]. How-
ever, it remains still essential to identify selective PtdIns5P binder
modules in order to better characterize its function. Using surface
plasmon resonance analysis, we identify in this study a PtdIns5P
partner harboring a strong selectivity for this lipid. This new part-
ner is the PH domain of another Dok family member, Dok-5.
T-cells are a major cell type from the adaptive immune system
that is involved in controlling the immune response. T-cell activa-
tion is initiated by the stimulation of the T-cell receptor (TCR).
Production of the PIs species such as PtdIns(3, 4, 5)P3 has beenlsevier B.V. All rights reserved.
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cently, we observed that PtdIns5P is produced in T-cells upon
TCR triggering. This production leads to Dok-1 and Dok-2 tyrosine
phosphorylation and subsequent T-cell signaling negative regula-
tion, suggesting that PtdIns5P is a second messenger downstream
of TCR stimulation [11].
Using PH-Dok-5 as a tool to sequestrate cognate PtdIns5P, as
well as IpgD to artiﬁcially increase the pool of PtdIns5P, we found
that PtdIns5P is indeed required for T-cell signaling. Altogether our
data argue for an early impact of PtdIns5P during T-cell activation.
PtdIns5P seems to be a newly identiﬁed player in T-cell signaling
and is able to activate Src family tyrosine kinases and Akt path-
ways that are crucial in T-cell activation.2. Materials and methods
2.1. Culture cells and transfection
Hut-78 T-cells were grown in RPMI 1640 medium supple-
mented with 10% heat inactivated FCS, 2 mM L-glutamine, and
1 mM sodium-pyruvate. For transfection, Hut-78 T-cells (107) were
electroporated at 960 lF and 250 V using the GenePulser Xcell™
(Bio-Rad).
2.2. Plasmid constructs
The construct bDNA4HADok-5 corresponding to the wild-type
(WT) full-length human Dok-5 cDNA tagged with HA epitope at
the N-terminus, was generated by subcloning of the pGEM-T easy
vector containing HA tagged Dok-5, described previously [15], into
the bDNA4 vector, using the restriction site NotI. The constructs
encoding the Dok-4 and Dok-5 PH domains fused to the GST pro-
tein were obtained by PCR ampliﬁcation of human Dok-4 [16] or
human Dok-5 tagged HA epitope, both in bDNA4 expression vector.
The PCR products were sequenced and cloned in pGEX-4T3 (Amer-
sham Biosciences Limited, England, UK).
The GFP-tagged Dok-5 PH domain construct was generated by
PCR ampliﬁcation from pGEX-4T3 PH-Dok-5 using the following
primers: sense 50-ggcgcctcgagatggcttccaattttaatgacatagtgaagcaag-
gg-30 (XhoI site added) and antisense 50-gcggcgaattcccttggatcc-
gtgttcctacacactccatctg-30 (EcoRI site added). The PCR products
were sequenced and cloned in pEGFP-N1 XhoI/EcoRI (Clontech,
Palo Alto, CA). Myc epitope-tagged IpgD WT and IpgD-C438S, a
phosphatase-dead mutant were in the pRK5 expression vector as
described previously [8].
2.3. Antibodies and Western blotting
CD3 mAb (clone 289) recognizing CD3e subunit of the CD3–TCR
complex was reported previously [17]. Anti-Myc epitope mAb,
9E10 and anti-phosphotyrosine mAb, 4G10 were purchased from
Millipore (Billerica, MA). Anti-GFP mAbs were purchased from
Roche (Meylan, France). The rabbit polyclonal antibodies recogniz-
ing Akt (#9272), phospho-LAT (Tyr191) (#3584), phospho-ZAP-70
(Tyr493) (#2704), phospho-Src family kinases (Tyr416) (#2101)
and the rabbit mAbs recognizing phospho-p44/42 MAPK (ERK-1/
2) (Thr202/Tyr204) (#4376), phospho-Akt (Ser473) (#4058) were
purchased from Cell signaling technology, Inc. Anti-GST mAb
ND2.1 was a kind gift of Dr. J.L. Teillaud (Inserm U872, Centre de
Recherche des Cordeliers, Paris, France).
For Western blotting, samples were resolved by standard 12%
SDS–polyacrylamide gels. Membranes were blocked and probed
with speciﬁc antibodies. Blots were then incubated with the
appropriate secondary antibodies, anti-rabbit IgG or anti-mouse
IgG, both conjugated with horseradish peroxidase (DAKO DenmarkA/S). Immunoreactive bands were visualized by enhanced chemi-
luminescence (Amersham Biosciences Limited, England, and UK).
2.4. Stimulation and cell lysates
Hut-78 T-cells (10  106) were stimulated at 37 C in RPMI
50 mM HEPES. Stimulations were carried out for the indicated
times using CD3 mAb 289 at 10 lg/ml. The cells were pelleted in
a microcentrifuge and lysed in buffer containing 50 mM HEPES
(pH 7.4), 1% Nonidet P-40, 150 mM NaCl, 20 mM NaF, 20 mM iodo-
acetamide, 1 mM phenylmethylsulfonyl ﬂuoride, 1 lg/ml protease
inhibitors (protease inhibitors cocktail, Sigma, St. Louis, MO) and
1 mM Na3VO4 for 10 min at 4 C, then centrifugated at
13 000 rpm for 10 min at 4 C.
2.5. Phospholipids binding assays
Protein–lipid blot assays were carried out as described [18].
‘‘PIP strip” membranes were purchased from Echelon biosciences
Inc. To reveal PIs–GST PH domains interactions, the anti-GST
mAb was used in immunoblotting.
2.6. BiaCore/surface plasmon resonance (SPR) experiments
Detailed protocols for SPR experiments were described
previously [19]. Brieﬂy, the binding of 1 lM protein was measured
on reconstituted liposomes containing 90% DOPC (1,2-dioleoyl-
sn-glycero-3-phosphocholine, Sigma) and 10% PtdIns or mono-
PtdInsP (Echelon biosciences Inc.) immobilized on L1 chips. At least
6000 RU of liposomes were coupled. Binding to PtdIns and
mono-PtdInsP were measured at the same time and all proteins
were tested on the same freshly prepared liposomes.
2.7. Luciferase assays
The promoter assay plasmids pIL-2-Luc composed of interleu-
kin II (IL-2) promoter, fused to ﬁreﬂy luciferase reporter gene
and pb-actin-Rluc composed of b-actin promoter, fused with Renil-
la luciferase gene were previously reported and luciferase assay
was performed as previously described [20]. PMA was purchased
from Sigma.
2.8. Phospho ﬂow by FACS analysis
Phospho ﬂow analysis was performed by cytometry as previ-
ously described [21]. Brieﬂy, cells were ﬁxed and permeabilized,
incubated with anti-phospho-Src Y416 (#2101, Cell Signaling
Technology) antibodies and appropriate biotinylated secondary
antibodies. Finally, revelation was performed using Streptavidin–
phycoerythrin solution (#IM3325, Beckman Coulter).3. Results
3.1. PtdIns5P increase is sufﬁcient to trigger downstream cell signaling
in T-cells
Ectopic IpgD expression induces high PtdIns5P production in
eukaryotic cells and activation of the PI 3-kinase/Akt pathway
[8,9]. To study the impact of IpgD and thereby of PtdIns5P increase
on T-cell signaling, Hut-78 T-cells were transfected with Myc-
tagged IpgD WT or a C438S (CS) mutant as control. The Hut-78
T-cell line was used because it is not mutated in key enzymes of
the PIs metabolism, such as the phosphatase and tensin homolog
deleted in chromosome 10 (PTEN) or the SH2 domain-containing
inositol polyphosphate 50-phosphatase (SHIP) as observed in Jurkat
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Fig. 1. T-cell signaling upon PtdIns5P increase in Hut-78 T-cells. (A) Cells were
transfected or not with myc-tagged IpgD WT or the kinase dead construct, IpgD CS.
Cell lysates were examined in Western blot after different periods of time, as
indicated. Note the Akt phosphorylation (pAkt) on Ser 473 upon IpgD expression
after 4 h transfection, most probably as a consequence of transient PtdIns5P
increase. (B) Phosphorylation of different signaling molecules in cells lysates of cells
transfected for 4 h with different expression vectors, as indicated on top. As a
positive control of phosphorylation pervanadate treatment was performed (pV). (C)
IpgD expression stimulates IL-2 promoter activity. Cells were transfected with a
luciferase reporter construct for IL-2 promoter activity and myc-tagged IpgD WT,
IpgD CS expressing constructs or an empty vector (mock). Luciferase activity was
measured 6 h after transfection. Results are expressed as the percentage obtained
by dividing the luciferase activity observed by the luciferase activity measured
when cells are stimulated by phorbol myristate acetate (PMA) plus ionomycin, a
treatment known to induce IL-2 promoter activity. Data show the average of three
independent experiments ± S.D.
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vation as detected by its phosphorylation at serine position 473 [9].
As shown in Fig. 1A, IpgD WT expression but not its phosphatase-
dead version leads to Akt phosphorylation at serine 473 4 h after
transfection. Thus, IpgD expression is also able to trigger signaling
events in this T-cell line.
TCR ligation activates protein tyrosine kinases (PTKs) like Src ki-
nase family members and ZAP-70, which regulate several signaling
events such as MAP kinases and PI3-kinase/Akt pathways [23]. To
determine whether PtdIns5P production could regulate some of
the TCR-mediated signaling events, activation of several PTKs
was analyzed using different anti-phosphoprotein antibodies on
lysates of IpgD WT or IpgD CS expressing cells (Fig. 1B). Pervana-
date treatment of Hut-78 T-cells was used as a positive control.
The Src kinase family members, but not ZAP-70 were tyrosine
phosphorylated upon IpgD expression. These results are in accor-dance with previous data demonstrating that IpgD enhances the
tyrosine phosphorylation of Src kinase substrates in T-cells such
as Dok-1 and Dok-2 proteins [11,24]. Moreover, the tyrosine phos-
phorylation of a ZAP-70 substrate, LAT was not increased in pres-
ence of IpgD WT, conﬁrming that PdtIns5P production does not
lead to ZAP-70 activation. The phosphorylation status of other sig-
naling proteins such as ERK-1/2, was not altered by IpgD expres-
sion. The activation of signaling pathways in T-cells results in the
production of several cytokines including IL-2, a key cytokine in-
volved into the T-cell development and proliferation during an
adoptive immune response. It has been reported that Akt can pos-
itively regulate the transcriptional activity of IL-2 [25]. To charac-
terize the role of PtdIns5P in T-cell signaling, we measured IL-2
promoter activity in Hut-78 T-cells (Fig. 1C). Therefore, Hut-78 T-
cells were co-transfected with an IL-2 promoter-dependent lucifer-
ase reporter plasmid and IpgD WT or IpgD CS. We used phorbol
myristate acetate (PMA) plus ionomycin treatment as a positive
control to determine the highest induction of IL-2 promoter activ-
ity in this cell system. Interestingly, we were able to detect a great
IL-2 promoter enhancement upon IpgD WT transfection as com-
pared to IpgD CS. However, a slight effect of catalytically-dead IpgD
is detectable. As IpgD is a bacterial protein, we assume that its
expression in mammalian cells may induce some cellular stress
response detectable both in the case of IpgD WT or CS forms that
may interfere at the level of gene expression. At the molecular
level, it has been reported that SigD, the ortholog of IpgD in Salmo-
nella typhimurium can interferes with Cdc42 functions indepen-
dently of its catalytic activity [26] suggesting that IpgD CS could
have also some direct effects. However, so far no functional protein
domain, apart its catalytic region, has been identiﬁed in the
peptide sequence of IpgD.
Altogether, these data suggest that PtdIns5P increase induces
positive activation events in T-cells.
3.2. Identiﬁcation of a new PtdIns5P binding module: the PH domain of
Dok-5 protein
To further establish that PtdIns5P enhances some T-cell signal-
ing events, we sought to identify a selective PtdIns5P interacting
domain, which could be used to sequestrate endogenous PtdIns5P
generated by TCR stimulation. We previously described Dok-1 and
Dok-2 PH domain binding-speciﬁcity [11]. These PH domains have
a double speciﬁcity for PtdIns4P and PtdIns5P with a preference for
PtdIns5P in a protein–lipid blot [11]. Moreover, PtdIns5P enhances
Dok-1 and Dok-2 phosphorylation levels. Here, we checked the li-
pid binding properties of the PH domains of two other Dok family
members also expressed in T-cells [15], Dok-4 and Dok-5 by fat
blotting (Fig. 2A) and SPR analysis (Fig. 2B).
To establish whether both Dok-4 and Dok-5 PH domains have
phospholipid-binding properties, we tested 15 lipids including
phosphoinositides in a protein–lipid blot (Fig. 2A). After incubation
with recombinant GST-PH Dok-5, a signal was detectable with
the phosphatidylinositol monophosphate species, PtdIns4P and
PtdIns5P. The spectrum of binding of the GST-PH Dok-4 is a bit
larger, since it recognizes also PtdIns3P. To further establish the
Dok-4 and Dok-5 PH domain binding properties, we used SPR anal-
ysis, a sensitive method to analyze monophosphorylated-PIs bind-
ing. SPR biosensor analysis revealed that the Dok-5 PH domain is
able to strongly bind PtdIns5P compared to the other tested mono-
phosphorylated-PIs (Fig. 2B and Supplementary Fig. S1). Dok-4 PH
domain is also able to bind PtdIns5P, but to a lesser extent and
with less selectivity. As positive controls, different known PI pro-
tein interactors were tested, GST-2X-FYVE Hrs [27], GST-PH OSBP
[28] and GST-2X PHD ING-2 [13] which bind respectively PtdIns3P,
PtdIns4P and PtdIns5P (Supplementary Fig. S1). In our experi-
ments, the dimer of the PHD domain of ING-2 failed to efﬁciently
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gether, our in vitro data revealed a strong and selective interaction
between Dok-5 PH domain and PtdIns5P, better than with any
other yet identiﬁed PtdIns5P binding domain.
3.3. The Dok-5 PH domain expression blocks T-cell signaling events
To validate the ability of the Dok-5 PH domain to block func-
tional events induced by PtdIns5P increase in T-cells, we next
investigated IL-2 promoter activity in IpgD-transfected T-cells in
the presence or absence of Dok-5 PH domain (Fig. 3A). To this
aim, Hut-78 cells were triple-transfected with the IL-2 promoter-
dependent luciferase reporter plasmid, with IpgD WT or IpgD CS
and with constructs encoding the GFP alone or the Dok-5 PH do-
main fused with GFP. Cells transfected with GFP alone showed ex-
pected feature with enhanced IL-2 promoter activity in the
presence of IpgD WT, in the same magnitude than previously ob-
served (Fig. 1C). Importantly, cells co-transfected with IpgD WT
and PH Dok-5 GFP, did not show any signiﬁcant increase of the
IL-2 promoter activity. This observation suggests that the PH do-
main of Dok-5 can sequestrate PtdIns5P preventing IpgD-induced
IL-2 promoter activity. Thus, the Dok-5 PH domain expression
blocks cellular effects induced by PtdIns5P increase, acting as a
‘‘PtdIns5P-downstream signaling inhibitor”. Endogenous TCR liga-
tion induced by CD3 mAbs stimulates transiently a cellular
PtdIns5P increase in Hut-78 T-cells [11]. We investigated the im-
pact of Dok-5 PH domain expression on TCR-induced signaling
events. Hut-78 T-cells were transfected or not with the GFP-tagged
Dok-5 PH domain, then stimulated by CD3 mAbs. The phosphory-
lation status of different signaling proteins was evaluated upon
TCR engagement in Western blot (Fig. 3B). As expected, TCR trig-
gering led to the activation of PTKs such as Src family members,and activation of both ERK-1/2 and Akt. The presence of Dok-5
PH domain blocked some TCR-induced tyrosine phosphorylation
events detected by anti-phosphotyrosine blots (Fig. 3B). TCR-in-
duced Src kinase family members and Akt phosphorylation, but
not ERK-1/2 phosphorylation, were largely decreased by the pres-
ence of the PH domain of Dok-5. These inhibitory effects on prox-
imal TCR-activated PTKs (Src family kinases) were conﬁrmed by a
second set of experiments using anti-phospho-Src (Tyr416) anti-
bodies in Western blot (Fig. 3C) or phosphoﬂow cytometry analysis
(Fig. 3D). By both experimental approaches, TCR-induced Src fam-
ily kinases activation signal was reduced in the presence of Dok-5
PH domain. These results correlate with data presented in Fig. 1,
suggesting that PdtIns5P impact on Src kinases and Akt activation
processes.4. Discussion
Altogether our ﬁndings suggest that PtdIns5P increase regulates
signaling events in T-cells. Some of them, such as the Akt activa-
tion, have been previously reported in epithelial cells [9]. Two
kinds of regulatory mechanisms have been suggested where
PtdIns5P increase prevents Akt dephosphorylation: (i) through an
inhibition of the PP2A phosphatase [29] or (ii) through a PTK acti-
vation that will phosphorylate YxxM motif-containing proteins in-
volved in the PI3-kinase class IA activation [9]. Here, we show that
at least in T-cells, the PtdIns5P increase induces an activation of Src
family members, where two of them, Lck and Fyn, are being largely
involved in T-cell signaling [23]. The activity of these Src kinases is
regulated within lipid rafts structures in T-cells [30]. As it has been
reported that some PIs signaling events occur in the raft nanodo-
mains [31], it is tempting to investigate the role of PtdIns5P located
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using inhibitors of the sphingolipid and cholesterol metabolism. As
other intracellular PtdIns5P pools have been described in late
endosomes and in the nucleus [32,33], we cannot exclude a partic-
ipation of these pools in the regulation of late T-cell activation
events such as the cytokine promoter activities.
Concerning Dok adaptor proteins, Dok-1, Dok-2, Dok-4 and
Dok-5 can be expressed in T-cells [15]. We reported that these pro-
teins can be classiﬁed into two subgroups based on bioinformatics
studies (Dok-1 and Dok-2 = group A and Dok-4 and Dok-5 = group
B). It has been reported that Dok family members harbor different
regulatory functions [34]. Thus, the different Dok members are
using different molecular mechanisms to generate negative feed-
back loops during T-cell activation [16,20]. Instead of the three
other DOK genes (DOK1, 2 and 4), DOK5 gene is only expressed
in pre-activated T-cells. This point will prompt us to study the
PtdIns5P generation in both naïve or effector/memory T-cells.
Finally, another point that will be critical to solve, is to identify
enzymes that directly produce PtdIns5P in T-cells. Few enzymes
have been identiﬁed in themetabolism of PtdIns5P [3]. Mammalian
PtdIns(4, 5)P2 4-phosphatases have been described, which are in-
volved in EGF-R receptor degradation [35]. The genes encoding
for these two 4-phosphatases are expressed in lymphoid cells as
well as the 5-kinase, PIKfyve, and the PtdIns(3, 5)P2 3-phosphatase
MTM1 which are both involved directly or indirectly in PtdIns5P
synthesis [36,37]. The analysis of the functions of these enzymes
in immune system, will help to understand how the lipid messen-
ger, PtdIns5P, participates in the ﬁne-tuning of T-cell signaling.Acknowledgments
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